This Under-the-Radar Stock Has Surged 1,300% Over the Past Year
Sol-Gel Technologies (SLGL) is a clinical-stage dermatology company focused on topical drugs for skin diseases. SLGL demonstrates exceptional technical momentum and is up 1,310% over the past 52 weeks....
SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know
We expect investors to focus on updates related to Sol-Gel Technologies, Ltd.’s SLGL ability to regain compliance with the recent Nasdaq requirement and other pipeline development activities when it...
Sol-Gel Technologies Approves Mori Arkin as Interim CEO; Provides Update on Clinical Trials and Financial Results
Mori Arkin appointed interim CEO; Sol-Gel reports ongoing clinical trials and recent financial developments.Quiver AI SummarySol-Gel Technologies, Ltd. announced that shareholders approved the appointment...